Table 1.
Non infected individuals and patients with Chagas disease analyzed in the study.
| ID | Clinical form | Age range per group (years) | LVDD(mm)* | LVEF(%)* |
|---|---|---|---|---|
| NI1 | Non-infected | ND | ND | |
| NI2 | Non-infected | ND | ND | |
| NI3 | Non-infected | ND | ND | |
| NI4 | Non-infected | ND | ND | |
| NI5 | Non-infected | ND | ND | |
| NI6 | Non-infected | 24–57 | ND | ND |
| I1 | Indeterminate | 50 | 71 | |
| I2 | Indeterminate | 48 | 60 | |
| I3 | Indeterminate | 41 | 64 | |
| I4 | Indeterminate | 50 | 55 | |
| I5 | Indeterminate | 53 | 60 | |
| I6 | Indeterminate | 18–72 | 48 | 68 |
| C1 | Cardiac | 75 | 21 | |
| C2 | Cardiac | 75 | 25 | |
| C3 | Cardiac | 48 | 62 | |
| C4 | Cardiac | 67 | 26 | |
| C5 | Cardiac | 48 | 66 | |
| C6 | Cardiac | 51–63 | 48 | 66 |
NI, non-infected individuals; I, indeterminate patients; C, cardiac patients; ID, identifier; LVDD, left ventricular diastolic diameter; LVEF, left ventricular ejection fraction, ND, not determined.
*
p < 0.05, when comparing the values of LVDD and LVEF between indeterminate and cardiac patients.